Standout Papers

Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Do... 2010 2026 2015 2020 412
  1. Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study) (2010)
    Antoine Dürrbach, Thomas C. Pearson et al. American Journal of Transplantation

Immediate Impact

2 by Nobel laureates 2 from Science/Nature 60 standout
Sub-graph 1 of 25

Citing Papers

The B7:CD28 family and friends: Unraveling coinhibitory interactions
2024 Standout
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
2024 Standout
2 intermediate papers

Works of J. Xing being referenced

Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients
2011
Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)
2010 Standout

Author Peers

Author Last Decade Papers Cites
J. Xing 30 189 528 225 11 702
M. Harler 13 170 440 243 13 583
Luis Gaite 25 162 513 254 7 691
Jatin Kothari 21 136 401 201 18 636
T. Shah 41 126 515 305 17 826
Thomas Waid 38 86 556 347 30 773
Manuel Arias 34 81 411 189 21 647
C F Barker 40 120 402 336 19 720
Jean-Louis Touraine 82 112 580 388 10 840
Santosh Potdar 38 107 285 251 20 632
José María Morales 9 117 410 164 17 636

All Works

Loading papers...

Rankless by CCL
2026